NV-HOHEM
8.1.2020 10:28:04 CET | Business Wire | Press release
CES 2020 will be held on January 7-10, 2020 in Las Vegas. During this grand gathering of global technology players, Hohem Technology Co., Ltd. (Hohem), as a dark horse in the portable gimbal industry, drew great attention of multiple buyers, journalists and third parties to its innovative and all-new smartphone gimbal iSteady X.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200108005299/en/
iSteady X, which will be officially launched in February 2020, is designed to solve the pain points of users with a foldable design and multiple creative functions like a 15-second video sharing button. Here are some highlights of the product.
The lightest
iSteady X stands out among others for it is the world's first lightweight handheld smartphone gimbal. Compared to traditional smartphone gimbals, iSteady X weighs only 249g, making it the world’s lightest three-axis smartphone gimbal. The lighter weight makes it easier to record your everyday life and journey.
Smaller
The foldable design makes iSteady X more compact and streamlined. Measuring only the size of a palm when folded up, it is convenient for users to carry around, hold in their hands, or put in their pockets, making it the ideal gadget for vloggers or those who like shooting with their smartphones.
Moment Mode, New Community APP
iSteady X has a set of buttons that allow users to instantly master the operation without pre-learning. Just by pressing one button, users can launch multiple modes including Moment Mode, Face-Tracking iSteady X is equipped with first-class anti-shake movement, the newest anti-shake algorithm iSteady, and the enhanced motor control scheme, so as to support a maximum load of 280g.
More information will not be released until its official release at CES 2020. Visitors at CES 2020 may go to booth 25953 to have a hand-on experience of Hohem products. Follow Hohem on Facebook : https://www.facebook.com/HohemGlobal/
About Hohem
Established in 2014, Hohem Technology Co., Ltd. (Hohem), adheres to its motto: Make the Moment, Enjoy it! It focuses on R&D and production of smart gimbals such as action camera gimbals, smartphone gimbals and DSLR gimbals.
The company has a solid technical foundation and has successfully launched the world’s first smartphone gimbal with face recognition function. Hohem is committed to providing users with simplistic, functional, and creative products. For details: https://www.hohem-tech.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200108005299/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer11.8.2026 14:30:00 CEST | Press release
Suha Jhaveri, Bill Warren and Jim Wassil added to ILiAD Board of Directors; Antony Blanc appointed Chief Business OfficerAppointments deepen vaccine development expertise and enhance global commercial and strategic leadership ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the appointments of Jim Wassil, currently Chief Operating Officer at Vaxcyte; Suha Jhaveri, former Strategic Advisor at Cidara before its acquisition by Merck; and Bill Warren, former Global Head of Antigen Design at Sanofi Vaccines, as independent members of ILiAD’s Board of Directors. The Company also announced the appointment of Antony Blanc, former VP, Head of Global Marketing and Global Strategic Pricing at GSK Vaccines, as Chief Business Officer. “Our recently appointed colleagues bring an extraordinary depth of experience in vaccine development, global commercialization, and strate
TEC reduces pressure on support teams with proactive outage communications powered by Adtran and GOCare11.8.2026 14:15:00 CEST | Press release
News summary: Fiber broadband providers need faster, more transparent ways to manage outages and reduce support surges TEC is now using GOCare OutageIQ integrated with Adtran’s outage notification API and Mosaic One to automate subscriber messaging Open APIs turn network insight into actionable workflows, improving responsiveness and operational efficiency Adtran and GOCare today announced that Telephone Electronics Corporation (TEC) has improved outage responses and reduced inbound support tickets using GOCare’s OutageIQ solution integrated with Adtran’s outage notification API and Mosaic One. Serving communities across Mississippi, Alabama and Tennessee, TEC delivers fiber broadband services built on a foundation of community investment and reliable service. By combining proactive notifications with real-time network insights, the service provider can now inform customers as issues are detected while equipping support teams with immediate context. This transparency helps build subscr
Kinaxis-Sponsored Study Identifies Supply Chain AI Accountability Gap Amidst Rapid Adoption Expectations11.8.2026 14:07:00 CEST | Press release
Trust, measurable outcomes, and governance lag, even as 41% expect autonomous-at-scale operations within two years Kinaxis® (TSX:KXS), a global leader in supply chain orchestration, today announced the findings of new independent research from IDC. The IDC InfoBrief, sponsored by Kinaxis, “Making Supply Chain AI Accountable,” reveals a growing chasm between organizations’ aggressive ambitions for autonomous AI adoption and their readiness to hold these advanced systems - which we believe underscores the need for a disciplined approach to AI investment and deployment to prevent costly failures and deliver measurable business value. What This Means for Supply Chain Leaders The IDC InfoBrief, which surveyed more than 2,000 supply chain leaders across nine global markets, found that while AI adoption is nearly universal - only 2% of respondents report no AI-enabled capabilities, and just 12% consider themselves AI leaders. Over half (52%) cite trust in AI-driven decisions as a top barrier
One in Four Executives Say AI Errors Have Reached External Audiences or Boards, According to New Research From Workiva11.8.2026 14:00:00 CEST | Press release
Although 84% of executives are at least somewhat confident in AI output without human review, only 11% believe their data quality is sufficient for AI use Workiva Inc. (NYSE: WK), a leading, audit-ready platform for trust, transparency, and accountability, today released findings from its 2026 Midyear Executive Benchmark Survey. Although 84% of surveyed executives say they are at least somewhat confident in the accuracy of AI output without human review, one in four (26%) say internal audits have detected AI errors that reached external audiences or board members. This data suggests there is a disconnect between what executives believe and what evidence shows. As AI reshapes the enterprise at unprecedented speed, a new risk is emerging: transformation could be outpacing the instincts of the leaders tasked with overseeing it. "Confidence in AI without control over data quality is a liability, not a strategy. CFOs need platforms that connect AI to trusted, auditable data so every output
Altasciences Continues to Expand North American Bioanalytical Footprint11.8.2026 14:00:00 CEST | Press release
Altasciences today announced a major expansion of its North American bioanalytical laboratory footprint, reinforcing its commitment to helping sponsors accelerate drug development through increased capacity, advanced automation, and harmonized scientific operations. The expansion includes a 4,000-square-foot addition to the company’s laboratory in Greater Montréal, which is expected to be fully operational by the end of Q3 2026. The company has also announced a new 13,000-square-foot purpose-built laboratory in Harleysville, Pennsylvania. Construction will proceed in phases, with Phase 1 scheduled for completion in Q1 2027. These investments significantly increase Altasciences' ability to support the growing demand for late-stage clinical bioanalysis while providing sponsors with greater flexibility, scalability, and operational resilience. Designed to support increasingly complex development programs, the expanded laboratories will result in increased capacity to conduct larger studie
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom